These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 18714742)

  • 21. Hemostatic changes in patients with liver cirrhosis.
    Ho CH; Hou MC; Lin HC; Lee FY; Wu JC; Lee SD
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Jun; 62(6):376-82. PubMed ID: 10389296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Coagulation disorders in cirrhosis].
    Téllez-Avila FI; Chávez-Tapia NC; Torre-Delgadillo A
    Rev Invest Clin; 2007; 59(2):153-60. PubMed ID: 17633804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute Kidney Injury in Decompensated Cirrhosis Is Associated With Both Hypo-coagulable and Hyper-coagulable Features.
    Zanetto A; Rinder HM; Campello E; Saggiorato G; Deng Y; Ciarleglio M; Wilson FP; Senzolo M; Gavasso S; Bulato C; Simioni P; Garcia-Tsao G
    Hepatology; 2020 Oct; 72(4):1327-1340. PubMed ID: 32614088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemostasis abnormalities in cirrhosis.
    Tripodi A
    Curr Opin Hematol; 2015 Sep; 22(5):406-12. PubMed ID: 26203733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemostatic disorders in liver cirrhosis (in relation to the extent of portal hypertension)].
    Liehr H; Hörder MH; Mersch-Baumert K
    Acta Hepatosplenol; 1971; 18(3):166-71. PubMed ID: 5089183
    [No Abstract]   [Full Text] [Related]  

  • 27. Cirrhotic coagulopathy: A rebalanced hemostasis.
    Singh AD; Mucha SR; Lindenmeyer CC
    Cleve Clin J Med; 2022 Sep; 89(9):523-533. PubMed ID: 37907441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patients with liver cirrhosis suffer from primary haemostatic defects? Fact or fiction?
    Violi F; Basili S; Raparelli V; Chowdary P; Gatt A; Burroughs AK
    J Hepatol; 2011 Dec; 55(6):1415-27. PubMed ID: 21718668
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coagulation abnormalities in the cirrhotic patient.
    Muciño-Bermejo J; Carrillo-Esper R; Uribe M; Méndez-Sánchez N
    Ann Hepatol; 2013; 12(5):713-24. PubMed ID: 24018489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hemostatic Alterations in Patients With Cirrhosis: From Primary Hemostasis to Fibrinolysis.
    Zermatten MG; Fraga M; Moradpour D; Bertaggia Calderara D; Aliotta A; Stirnimann G; De Gottardi A; Alberio L
    Hepatology; 2020 Jun; 71(6):2135-2148. PubMed ID: 32090357
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hemostatic defects in end stage liver disease.
    Kujovich JL
    Crit Care Clin; 2005 Jul; 21(3):563-87. PubMed ID: 15992673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: Guidance from the SSC of the ISTH.
    Roberts LN; Lisman T; Stanworth S; Hernandez-Gea V; Magnusson M; Tripodi A; Thachil J
    J Thromb Haemost; 2022 Jan; 20(1):39-47. PubMed ID: 34661370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Coagulation studies in patients with cirrhosis of liver: bleeders vs non-bleeders.
    Rastogi P; Gupta SC; Bisht D
    Indian J Pathol Microbiol; 1990 Oct; 33(4):323-7. PubMed ID: 2132499
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
    Tripodi A; Salerno F; Chantarangkul V; Clerici M; Cazzaniga M; Primignani M; Mannuccio Mannucci P
    Hepatology; 2005 Mar; 41(3):553-8. PubMed ID: 15726661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hemostatic defects in liver and renal dysfunction.
    Mannucci PM; Tripodi A
    Hematology Am Soc Hematol Educ Program; 2012; 2012():168-73. PubMed ID: 23233577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The evaluation of hemostatic disorders in patients with systemic lupus erythematosus].
    Arshinov AV; Lapin VA; Raĭt IuA
    Ter Arkh; 1999; 71(5):38-40. PubMed ID: 10399229
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coagulation testing and management in liver disease patients.
    Stotts MJ; Davis JPE; Shah NL
    Curr Opin Gastroenterol; 2020 May; 36(3):169-176. PubMed ID: 32141899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
    Potze W; Adelmeijer J; Porte RJ; Lisman T
    Thromb Res; 2015 May; 135(5):1012-6. PubMed ID: 25746364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Platelet function and blood coagulation in hepatic cirrhosis.
    Manikeri SR; Raghu CN; Dadkar VN; Sheth UK
    J Assoc Physicians India; 1979 Dec; 27(12):1067-70. PubMed ID: 549915
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.